Zevra Therapeutics (ZVRA) Short-term Investments (2015 - 2026)
Zevra Therapeutics' Short-term Investments came in at $76.25 million for Q2 2026, down 50.8% from $154.9 million a year earlier and down 27.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Short-term Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Short-term Investments was $128.61 million, up 260.1% from FY2024.
- Short-term Investments has increased in each of the last three years, with a three-year compound annual growth rate of 96.7% (FY2022 to FY2025).
- Going back by year, Short-term Investments was $35.71 million in FY2024 (+44.6%), $24.69 million in FY2023 (+46.1%) and $16.9 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Short-term Investments since Q1 2025.
- Year-over-year, Short-term Investments increased in five of the last seven quarters, with growth averaging 146.5%.
- The fastest year-over-year change in Short-term Investments over five years came in Q3 2023 (growth of 580.2%), and the weakest in Q1 2024 (a decline of 71.3%).
- Business Quant data shows ZVRA's Short-term Investments at $105.02 million (Q1 2026), $128.61 million (Q4 2025) and $145.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.25 Mn |
| Mar 31, 2026 | 105.02 Mn |
| Dec 31, 2025 | 128.61 Mn |
| Sep 30, 2025 | 145.07 Mn |
| Jun 30, 2025 | 154.90 Mn |
| Mar 31, 2025 | 25.29 Mn |
| Dec 31, 2024 | 35.71 Mn |
| Sep 30, 2024 | 35.34 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 9.87 Mn |
| Dec 31, 2023 | 24.69 Mn |
| Sep 30, 2023 | 39.67 Mn |
| Jun 30, 2023 | 20.70 Mn |
| Mar 31, 2023 | 34.40 Mn |
| Dec 31, 2022 | 16.90 Mn |
| Sep 30, 2022 | 5.83 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2018 | 3.26 Mn |
| Sep 30, 2018 | 11.24 Mn |
API Access
Zevra Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();